Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa (Duodopa®) in Sweden
Willis M, Persson U, Zoellner Y & Gradl B
Applied Health Economics and Health Policy, 2010; 8(6): 377-86
DOI: 10.2165/11531160